Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $114,085 - $132,071
854 New
854 $127,000
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $19,522 - $22,482
-135 Reduced 8.73%
1,411 $224,000
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $13,831 - $16,587
-100 Reduced 6.08%
1,546 $250,000
Q3 2022

Oct 27, 2022

SELL
$134.21 - $153.93 $11,810 - $13,545
-88 Reduced 5.07%
1,646 $221,000
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $154,409 - $196,305
-1,122 Reduced 39.29%
1,734 $266,000
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $28,111 - $34,878
-213 Reduced 6.94%
2,856 $463,000
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $26,857 - $33,982
-250 Reduced 7.53%
3,069 $346,000
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $26,600 - $30,195
250 Added 8.15%
3,319 $358,000
Q2 2021

Jul 15, 2021

SELL
$105.21 - $117.21 $15,781 - $17,581
-150 Reduced 4.66%
3,069 $346,000
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $100,765 - $110,930
985 Added 44.09%
3,219 $348,000
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $179,814 - $242,768
2,234 New
2,234 $239,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $135,909 - $159,513
-1,582 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $116,071 - $155,320
1,582 New
1,582 $156,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Reitz Capital Advisors LLC Portfolio

Follow Reitz Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reitz Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reitz Capital Advisors LLC with notifications on news.